SYNGENENSESYNGENE INTERNATIONAL LTD· Healthcare ServicesHighPositive
Announced Thu, 10 Sept, 2026 · 17:18 IST

Syngene remits final dividend of Rs 1.25/share for FY 2025-26

SYNGENE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.2%Reaction day
₹384.00
prior close
₹383.25
announcement price
After-mkt
timing
Nifty Smallcap 250market-0.5%+0.3% vs market
Healthcare Research Analytics & Technology peers, median of 5sector+0.4%-0.6% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Smallcap 250 and 0.6 pts less than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.9
10m
-1.1
15m
-1.5
30m
-1.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.2-0.5+0.3+0.4-0.6
Next day
-1.4-2.9+1.5-1.2-0.2
2d
-1.0-3.1+2.1-0.8-0.2
3d
-1.0-2.3+1.3+0.1-1.1
4d
-4.2-0.8-3.4-4.8+0.6
5d
+0.4-0.8+1.3-1.5+2.0
1w
-0.6-0.1-0.5-4.3+3.7
15d
-5.7-2.9-2.8-9.4+3.7
1m
-2.6-3.6+1.0-16.1+13.5
2m
—————
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Syngene International has remitted the final dividend of 12.50% (Rs 1.25 per equity share on face value Rs 10) for FY 2025-26, approved at the AGM held on July 29, 2026. The record date was June 26, 2026. The dividend has been credited electronically or sent via warrant based on shareholder mandates. Shareholders who haven't received the credit can contact KFin Technologies, the Registrar and Transfer Agent.

Likely market impact

Shareholders on the record date receive Rs 1.25 per share; routine dividend payout, no change to business outlook.